Get the Stockscreener App
79.50
0.06%
-0.05
Pre-market:
78.31
-1.19
-1.50%
Inari Medical Inc stock is traded at $79.50, with a volume of 2.94M.
It is down -0.06% in the last 24 hours and up +43.37% over the past month.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$79.55
Open:
$79.54
24h Volume:
2.94M
Relative Volume:
1.46
Market Cap:
$4.66B
Revenue:
$574.50M
Net Income/Loss:
$-78.58M
P/E Ratio:
-58.89
EPS:
-1.35
Net Cash Flow:
$1.58M
1W Performance:
+0.25%
1M Performance:
+43.37%
6M Performance:
+44.81%
1Y Performance:
+38.28%
1-Day Range:
$79.44
$79.61
1-Week Range:
$79.29
$79.61
52-Week Range:
$36.73
$79.69
Inari Medical Inc Stock (NARI) Company Profile
Name
Inari Medical Inc
Sector
Industry
Phone
949-923-4747
Address
6001 OAK CANYON, SUITE 100, IRVINE, CA
Compare NARI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
79.50 | 4.66B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Sep-18-24 | Initiated | Stifel | Hold |
| Sep-03-24 | Initiated | Leerink Partners | Market Perform |
| Aug-09-24 | Initiated | Deutsche Bank | Buy |
| Jul-25-24 | Initiated | William Blair | Outperform |
| Jul-18-24 | Downgrade | Needham | Buy → Hold |
| Feb-29-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-23-24 | Initiated | Needham | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-29-22 | Initiated | Berenberg | Buy |
| Sep-13-22 | Initiated | Truist | Hold |
| Jun-21-22 | Initiated | Piper Sandler | Overweight |
| Mar-23-22 | Resumed | BofA Securities | Buy |
| Dec-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-18-20 | Initiated | BTIG Research | Buy |
| Oct-29-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-28-20 | Initiated | SVB Leerink | Outperform |
| Jun-19-20 | Initiated | Canaccord Genuity | Buy |
| Jun-16-20 | Initiated | BofA/Merrill | Neutral |
| Jun-16-20 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-16-20 | Initiated | Wells Fargo | Equal Weight |
View All
Inari Medical Inc Stock (NARI) Latest News
AMI Asset Management Corp Takes $1.65 Million Position in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025? - MSN
Uncovering the Best Performing Mid-Cap Stocks! Don't Miss Out! - Jomfruland.net
Stryker begins tender offer for Inari Medical shares at $80 each By Investing.com - Investing.com South Africa
Stryker begins tender offer for Inari Medical shares at $80 each - MSN
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical - MSN
Stryker commences $80 per share cash offer for Inari Medical - TipRanks
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc. - The Manila Times
Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing - MSN
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice - MSN
Here’s Why Jim Cramer Backs Stryker (SYK)’s $4.9 Billion Inari Medical Acquisition - Insider Monkey
Stryker agrees to acquire Inari Medical for $4.9bn - MSN
Stryker to Acquire Inari Medical for $4.9B - Orange County Business Journal
Here’s Why Inari Medical Inc. (NARI) Led This Week’s Rally - MSN
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters
Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect - AccessWire
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? - Benzinga
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders - GlobeNewswire Inc.
Here’s Why Inari Medical Inc. (NASDAQ:NARI) Is Skyrocketing - MSN
Inari Medical soars on Stryker acquisition - MSN
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical - MSN
Stryker to acquire Inari Medical in $4.9 billion deal, expand into peripheral vascular segment - DOTmed HealthCare Business News
These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, FuboTV, Inari Medical, Denali Therapeutics, and More - MSN
Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath? - MSN
Director William Hoffman Sells 200,000 Shares of Inari Medical I - GuruFocus.com
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation - AccessWire
Inari Medical Acquired by Stryker for $4.9 Billion - MSN
Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock? - MSN
Inari medical director William Hoffman sells $12.1 million in stock By Investing.com - Investing.com Canada
Inari medical director William Hoffman sells $12.1 million in stock - Investing.com India
Inari Medical, Inc. (NASDAQ:NARI) Director Sells $12,094,000.00 in Stock - MarketBeat
Stryker Eyes Acquisition Of Inari Medical For Expansion In Venous Treatments - Finimize
William Blair Downgrades Inari Medical (NARI) - MSN
Inari Medical's (NARI) Neutral Rating Reiterated at BTIG Research - MarketBeat
Inari Medical (NASDAQ:NARI) Surges on Buyout From Stryker - TipRanks
Stryker buyout prompts downgrade of Inari Medical stock at Canaccord By Investing.com - Investing.com Nigeria
StrykerStarting 2025 With A Bolt-On Deal For Inari Medical (NYSE:SYK) - Seeking Alpha
Device maker Stryker strikes $4.9 billion deal for Inari Medical - MSN
Heart device impresses FDA | Stryker acquires Inari Medical for $4.9B | CES 2025 | Limiting TAVR complications - Cardiovascular Business
Inari Medical (NASDAQ:NARI) Rating Lowered to "Hold" at Baird R W - MarketBeat
Stryker’s Strategic Acquisition of Inari Medical Announced - Yahoo Finance
Wells Fargo Downgrades Inari Medical (NARI) - MSN
Jefferies cuts Inari Medical stock rating, raises target to $80 By Investing.com - Investing.com South Africa
Stryker Acquires Inari Medical in a $4.9 Billion All-Cash Deal - GuruFocus.com
10 Firms Post Strong Gains Amid Wall Street Bloodbath - Insider Monkey
Inari Medical stock downgraded—unlikely competing offers to emerge By Investing.com - Investing.com Nigeria
Stryker Corporation (SYK) Announces Merger Agreement with Inari Medical - GuruFocus.com
Stocks to Watch Recap: Nvidia, Meta, Toyota, Inari Medical - The Wall Street Journal
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc.NARI - The Malaysian Reserve
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc.NARI - Business Wire
Inari Medical stock rating cut to Neutral at BTIG - Investing.com India
Inari Medical Inc Stock (NARI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):